News

A recent study sheds light on the timing of antibiotic administration in patients with suspected sepsis, suggesting that giving β-lactam antibiotics before vancomycin may lead to better outcomes.

A recent study conducted across five centers in Shelby County, Tennessee, reveals concerning disparities in the diagnosis and severity of axial spondyloarthritis (axSpA) in Black Americans.

An international expert panel of 43 dermatologists has established an expert consensus on the off-label use of low-dose oral minoxidil (LDOM) for treating hair loss.

A recently published review article has shed light on significant breakthroughs in the understanding and treatment of IgG4-mediated autoimmune diseases, particularly in the realm of autoimmune neuropathies.

Respiratory failure impacts millions annually in the U.S., leaving many survivors with lasting physical, cognitive, and quality-of-life impairments.

A recent Phase II clinical trial has revealed promising results for men with low-grade prostate cancer on active surveillance (AS).

In an effort to improve psoriasis research, the VISIBLE clinical trial has made significant strides in diversity, enrolling participants with skin of color (SoC) at an accelerated rate.

Tuberculosis (TB) remains a persistent health concern among migrants to low-TB-incidence countries, including Canada.